ARCHIVES

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979

Screening Frequency for Cervical Cancer May Be Reduced, ACS Says

November 22, 2002

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

October 28, 2005

In Brief: ASCO Letter To Clinton Urges support For Trials; Senator Praises NCI, Bristol; Berlin Back A NCI

January 15, 1993

Hugh Creech, Fox Chase Chemotherapy Pioneer, Dead at 92

January 31, 2003

Rall Says NTP to Put 50-75 Chemicals On Long Term Tests

January 19, 1979